Alain Dugal
Fortuna: 7 490 $ al 31/05/2026
Fortuna: 7 490 $ al 31/05/2026
Mr. Alain R.
Dugal is a Chief Operating Officer & Executive Vice President at LSL Pharma Group, Inc. Mr. Dugal was previously employed as a Vice President-Manufacturing & Logistics by Crescita Therapeutics, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LSL PHARMA GROUP INC 0,02 % | 28/05/2026 | 29.487 ( 0,02 % ) | 7 490 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LSL PHARMA GROUP INC. | Director de Operaciones | 28/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | Corporate Officer/Principal | 01/10/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Crescita Therapeutics, Inc.
Crescita Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the production and development of topical products for treating medical conditions in dermatology and pain | Health Technology |
LSL Pharma Group, Inc.
LSL Pharma Group, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops, manufactures and distributes natural health products & dietary supplements | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.